CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology
试验速览
- 阶段
- 不适用
- 入组人数
- 650
- 试验地点
- 1
- 主要终点
- Lung histology
研究概览
简要总结
Lung cancer remains the leading cause of cancer related mortality worldwide, with more than 1.5 million related deaths annually. Lung cancer is divided into two main groups: Small Cell Lung Carcinoma (SCLC) and Non-Small Cell Lung Carcinoma (NSCLC), with prevalence of ~20% and 80% respectively. NSCLC is further subdivided into adenocarcinoma (the most common), squamous cell carcinoma (SCC), and large cell carcinoma. Furthermore, each subtype is likely to have specific mutations, which could be targeted for treatment.
Medical imaging and radiomics feature extraction represent a candidate alternative to conventional tissue biopsy, a theory that is investigated in this study.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Availability of diagnostic non-contrast enhanced CT scan.
- •Availability of histologic tumor analysis results
排除标准
- 未提供
结局指标
主要结局
Lung histology
时间窗: December 2019
Is the tumor under investigation an adenocarcinoma of the lung?
次要结局
未报告次要终点